US FDA Gene Therapy Review Reorg Draws Congressional Interest

 
• By Michael McCaughan
  
gene therapy
The House Energy and Commerce Committee wants more information on CBER's new Office of Therapeutic Products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies